Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Behav Res Ther. 2013 Sep 26;51(12):10.1016/j.brat.2013.09.006. doi: 10.1016/j.brat.2013.09.006

Table 5.

Medication Consumption Means (SDs) During PSG Nights

Baseline
Posttreatment
1-yr Follow-up
M SD M SD M SD
CBT 2.6 2.0 0.04 0.2 0.2 0.5
PL 3.8 3.2 0.5 1.0 0.9 2.5
MED 2.0 1.4 0.2 0.6 0.2 0.5

Treatment Groups = CBT, cognitive-behavior therapy; PL, placebo; MED, medication withdrawal only.

Medication use was measured in units of number of lowest recommended doses, LRDs.

Reported values are mean nightly LRD consumption in the sleep lab.